Key result
Treatment with colchicine led to the resolution of chest pain within 24 hours and complete resolution of pericardial effusion at 3 weeks in a patient with delayed COVID-19 complications.
Why the study?
COVID-19 patients typically present with respiratory symptoms, but cardiac complications such as pericarditis and pericardial effusion have also been reported.
Population
One patient with acute pericarditis and pericardial effusion as a delayed complication of COVID-19
Design
Case report
Authors
Loading...
May support colchicine for delayed post-COVID pericarditis; hypothesis-generating and requires prospective trials before practice change.
Case Report (n=1)
No
Acute pericarditis and pericardial effusion can occur as a delayed complication of COVID-19 and may be successfully treated with colchicine.
Soewono et al. (2021) conducted a case report in Pericarditis with pericardial effusion (n=1). Colchicine was evaluated on Resolution of symptoms and effusion. Treatment with colchicine led to the resolution of chest pain within 24 hours and complete resolution of pericardial effusion at 3 weeks in a patient with delayed COVID-19 complications.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: